CYTOMEGALOVIRUS COLITIS POST IL-6 INHIBITOR USE IN COVID-19 INFECTION

被引：4
作者：
Jiwa, Nasheena
Lorick, Kiran
Mutneja, Rahul
机构：
来源：
CHEST | 2020年 / 158卷 / 04期
关键词：
D O I：
10.1016/j.chest.2020.08.719
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：772A / 772A
页数：1
相关论文
共 3 条
[1]   Elevated interleukin-6 and severe COVID-19: A meta-analysis [J].
Aziz, Muhammad ;
Fatima, Rawish ;
Assaly, Ragheb .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (11) :2283-2285
[2]   Efficacy and safety of sarilumab in patients with active rheumatoid arthritis [J].
McCarty, Delilah ;
Robinson, April .
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (03) :61-67
[3]   Cytomegalovirus infection in critically ill patients: a systematic review [J].
Osawa, Ryosuke ;
Singh, Nina .
CRITICAL CARE, 2009, 13 (03)
1